FDA Approves Controversial ‘Little Pink Pill,' With Restrictions

The Food and Drug Administration has approved a pill that aims to increase a woman's desire for sex - a controversial decision made only after an extended lobbying campaign by the drug's makers, NBC News reported.

But the agency's imposed an unusual number of restrictions on who can prescribe the drug and how they can prescribe it -- moves aimed at minimizing concerns over its side-effects.

The pill's called flibanserin and will be marketed under the brand name Addyi. The FDA is asking its maker, Sprout Pharmaceuticals, to specially train doctors and pharmacists who dispense it and to keep track of any problems with women taking the drug.

The FDA had rejected the drug twice before. Sprout helped wage a public relations campaign called "Even the Score," claiming that while men have many different sexual dysfunction drugs to choose from, including Viagra and Cialis, women have none.

Copyright AP - Associated Press
Contact Us